Using HR in controlling prescription drug cost
https://cdn.aarp.net/content/dam/aarp/health/drugs_supplements/2016/04/1140-new-coalition-pushesfor-lower-prescription-drug-costs.imgcache.rev.web.900.513.jpg
Introduction
The drug prices in our country and almost most of the
countries tend to increase year by year. The costs are rising in excess of
general and medicinal cost inflation, which leads to call of a price hike.
specialty
pharmaceuticals, including those derived from living cells or organisms
(referred to as “biologics”), are much more complex than traditional prescription
drugs, both in their makeup and in how they are administered to the
patient. These medications:
- Injections or infused in a health care setting at a
doctor’s office, clinic or hospital, with follow-up care and monitoring
also necessary.
- Are used to treat complex, often chronic conditions,
including certain types of cancer and multiple sclerosis, for which there
are few if any other treatment options.
- Are expensive or expensive. A single dose can cost
hundreds or thousands of dollars.
Reasonable
people may interpret the data and institutions in a different perspective than
the above-mentioned medication pricing viewpoint. If my viewpoint is accepted,
it will have policy ramifications. Why do some customers receive such fantastic
bargains, and how might government health insurance plans join in marketplaces
so that they can achieve comparable prescription prices? Medicaid has chosen
the approach of mandating manufacturers to offer Medicaid prices (in the form
of rebates) that are competitive with the best private-sector price. Because
such rules alter the economics of granting price discounts to all customers,
the private price has increased
Solutions
As specialty medications grow increasingly
widespread across all therapy groups, you may be tempted to ask employees to
foot a larger share of the bill—perhaps by implementing co-insurance, which
compels employees to pay a percentage of the prescription cost rather than a
flat dollar co-payment
Disease management programs can also direct
patients to the least expensive specialty medicine delivery facility. Some
physicians may prefer to deliver the drug in a hospital setting; however, a
physician's office or retail clinic could be just as safe and effective while
costing far less.
-
Anon., . Character education: our shared
responsibility. [Online]
Available at: http://www2.ed.gov/admins/lead/character/brochure.html
[Accessed 6 12 2021].
Columbaro,
N. L. & Monaghan, C. H., 2009. Employer Perceptions of Online Degrees: A
Literature Review.. Online Journal of Distance Learning Administration, ,
12(1), p. .
Frank, R.
G., 2001. Prescription Drug Prices: Why Do Some Pay More Than Others Do?. Health
Affairs, , 20(2), pp. 115-128.
Kleinke,
J., 2001. The Price Of Progress: Prescription Drugs In The Health Care
Market. Health Affairs, , 20(5), pp. 43-60.
Merrick,
A., 2019. Education Benefits Present a Learning Opportunity. SHRM.
Nichols,
S., Nixon, H., Pudney, V. & Jurvansuu, S., 2009. Parents resourcing
children’s early development and learning. Early Years, , 29(2), pp.
147-161.
Sammer, J.,
2017. How HR Can Help Control Prescription Drug Costs. SHRM, Issue
may 2017.
w_AM, e.
n., 2004. Adult and community education. [Online]
Available at: http://epsom-ewell.gov.uk/eebcweb/templates/general.aspx?nrmode=published&nrnodeguid={fe1186dd-6c80-4027-a133-88b754296f6f}&nroriginalurl=/eebc/education+and+learning/adult+and+community+education/&nrcachehint=nomodifyguest
[Accessed 6 12 2021].
This comment has been removed by the author.
ReplyDeleteManaging prescription is difficult and necessitates specific knowledge. To allow pharmacy benefit managers (PBMs) or other consultants to closely monitor and manage spending, many bigger businesses choose to split these programs from the broader health plan. A rising number of businesses are segmenting their speciality drug programs so that they can be managed by specialty pharmacies, specialized PBMs, and other suppliers.
ReplyDeleteHR professionals from smaller businesses that rely on insurance providers to run their health plans, which include pharmaceutical coverage, have fewer options. However, they can still exert pressure on carriers by inquiring about their cost-cutting efforts.